Buchang Pharma plans to jointly inject a total of 4 million yuan in cash with other shareholders of its holding subsidiary Jinan Buchang Yingxi Trading Company, at a price of 1 yuan per share, in proportion to their existing shareholdings. After the capital increase, the registered capital of Buchang Yingxi Trading will rise from 1 million yuan to 5 million yuan, with Buchang Pharma contributing 3.6 million yuan and maintaining its 90 percent stake. In the first quarter of 2026, Buchang Pharma recorded revenue of 2.579 billion yuan and net profit attributable to the parent of 320 million yuan.
Shandong Buchang Pharmaceuticals Co LtdBuchang Pharma invests 3.6 million yuan in a proportional capital increase for its holding subsidiary, maintaining its 90% stake; the move is a routine capital injection with no clear positive or negative signal.
Jinan Buchang Yingxi Trading receives a capital increase of 4 million yuan, raising registered capital from 1 million to 5 million yuan, which strengthens its balance sheet.